|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
German Clinical Trials Register |
|
Last refreshed on:
|
8 April 2024 |
|
Main ID: |
DRKS00009812 |
|
Date of registration:
|
05/04/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
REnal Function in Ambulatory CarE
|
|
Scientific title:
|
REnal Function in Ambulatory CarE
- REFACE |
|
Date of first enrolment:
|
01/04/2015 |
|
Target sample size:
|
|
|
Recruitment status: |
Complete |
|
URL:
|
http://drks.de/search/en/trial/DRKS00009812 |
|
Study type:
|
observational |
|
Study design:
|
Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: health services research
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Contacts
|
|
Name:
|
Jean-François Chenot
Wirkner |
|
Address:
|
Fleischmannstraße 6
18055
Greifswald
Germany |
|
Telephone:
|
03834-8622293 |
|
Email:
|
jchenot@uni-greifswald.de |
|
Affiliation:
|
Abteilung Allgemeinmedizin, Institut für Community Medicine, Universitätsmedizin Greifswald |
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: The original cohort study (SHIP-2) included a two-stage stratified cluster sample of adults aged 20–79 years drawn from the population of western Pomerania.
Our study is based on a follow-up of this cohort, approximately 11 years later.
The sample is population-based.
Exclusion criteria: -
Age minimum:
30 Years
Age maximum:
90 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic kidney disease
|
N18
N19
|
|
Unspecified kidney failure
|
|
Intervention(s)
|
|
Group 1: Observational study, using data from the SHIP-2 cohort study in combination with secondary data, coding and monitoring of chronic kidney disease by ambulatory care practitioners is evaluated
|
|
Primary Outcome(s)
|
|
Percentage of CKD patients who are coded as having CKD in secondary data.
|
|
Secondary Outcome(s)
|
|
Percentage of CKD patients in different stages of CKD, who are coded as having CKD.
|
|
Source(s) of Monetary Support
|
|
KFH Kuratorium für Dialyse und Nierentransplantation e.V. (KFH)
|
|
Ethics review
|
Status: Approved
Approval date: 19/06/2008
Contact:
ethik@med.uni-greifswald.de
Ethikkommission an der Universitätsmedizin Greifswald, Institut für Pharmakologie
+49-3834-865644
ethik@med.uni-greifswald.de
|
|